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.2013.02.Abstract Background: Mannitol can be negative for outcome, which may explain why we lack sci-
entiﬁc support for its use. The purpose of this study was to compare the brain relaxation and elec-
trolyte balance in group of patients with posterior fossa tumor underwent surgery in sitting position
with or without mannitol.
Methods: Eighty patients scheduled for resection of posterior fossa tumor from April 2009 till
April 2012 were enrolled in this prospective, double-blind, randomized study. All cases received
general anesthesia and attained sitting position during surgery. Patients were enrolled into two
groups, group I received mannitol (20%) 1 gm/kg just before opening the dura. Group II received
placebo at the same time. Hemodynamics, duration of surgery, Brain Relaxation Score (BRS) in
which surgeons assessed the condition of the brain as 1 = perfectly relaxed, 2 = satisfactorily
relaxed, 3 = ﬁrm (leveled) brain, 4 = bulging brain were recorded. Blood losses, urine output
and serum sodium and potassium levels were assessed. Any operative complications were recorded.
Results: No difference in hemodynamics (HR and MBP) whereas CVP with mannitol was higher
than with placebo (p< 0.01). No difference in brain relaxation score (p= 0.719) or operative1001637298.
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256 S.A. Mousa et al.complication between both groups. Mannitol was associated with higher urine output (p< 0.001),
higher serum potassium and osmolarity (p< 0.001) and lower serum sodium (p< 0.001) than com-
pared with placebo.
Conclusion: Surgery for posterior fossa in sitting position could be safely performed without the
use of mannitol avoiding its adverse side effects with beneﬁcial effects in terms of preserving hemo-
dynamic, electrolytes balance, reasonable brain relaxation and fewer complications.
ª 2013 Egyptian Society of Anesthesiologists. Production and hosting by Elsevier B.V.
Open access under CC BY-NC-ND license.1. Introduction
Intra operative patient positioning involves balancing surgical
comfort, against the risks related to the patient position.
Therefore, patient positioning during surgery should be con-
sidered during the preoperative evaluation [1].
Since our neurosurgical colleagues frequently require set-
ting up the patients during surgery, its problems should be
common knowledge and techniques aimed at their solution
should be widely understood. Sitting position is most com-
monly utilized for posterior fossa surgery and cervical lami-
nectomy. Shapiro and Drummond have demonstrated that
the sitting position is still utilized for posterior fossa surgery
in about half of practices in USA [2]. Hemodynamic instabil-
ity is commonly associated with the sitting position during
anesthesia, resulting primarily from a sudden decrease in intra
thoracic blood volume. Because brain tumors may cause dis-
turbances of cerebral auto regulation and the blood–brain
barrier, in addition to the effects of an infusion of mannitol
on serum osmolality, systemic hemodynamic, and blood vol-
ume; all these effects could possibly have an unfavorable
inﬂuence on brain condition [3,4]. Moreover, because no pre-
vious data on this subject could be found in the relevant lit-
erature, we decided to study the effects of undergoing
posterior fossa tumor resection during sitting position without
the use of mannitol on systemic hemodynamic, blood electro-
lytes, osmolarity and the brain relaxation versus conventional
dose of mannitol.
Mannitol is a sugar alcohol (C6H14O6) with a molecular
weight of approximately 182 kDa, is not signiﬁcantly metabo-
lized and osmolarity = 1098 mOsm/l, and is excreted un-
changed in the urine. It is ﬁltered at the glomerulus and is
reabsorbed in the nephron, thereby acting as an osmotic diure-
tic. The half-life is affected by glomerular ﬁltration rate (GFR)
but averages from 39 to 103 min [5]. Osmotherapy, with man-
nitol is considered the standard of care by most of neuroanes-
thesiologists. From side effects related to renal and pulmonary
system, electrolyte disturbances, and a rebound increase in
ICP, osmotherapy can be negative for outcome. These draw-
backs, and the fact that the most recent Cochrane meta-anal-
yses of osmotherapy in brain edema could not ﬁnd any
beneﬁcial effects on outcome, make routine use of osmother-
apy during the surgery for brain tumor with sitting position
is doubtful. In order to counteract this physiologic response,
anesthesiologists frequently try to reduce the consumption of
the drugs exposing patients to the potential risk of being hemo-
dynamically and metabolic unstable like osmotic diuretics. It is
thus important to investigate the brain condition during resec-
tion of posterior fossa tumors while the patients attaining the
sitting position without the use of osmotic diuretic.2. Patients and methods
In this prospective, double blind and randomized study, we
recruited 80 patients, with American Society of Anesthesiol-
ogists (ASAs) grades I and II, and diagnosed as infratento-
rial tumors, into the study from April 2009 till April 2011.
Seventy-seven of those patients completed the study. Writ-
ten informed consent and approval of the hospital ethical
committee were taken before starting the study. All patients
were admitted in Neurosurgery Department at Mansoura
University Hospital for brain tumor resection performed
by one of senior staff of the neurosurgeons under general
anesthesia in sitting position. None of the patients had a
history of cardiopulmonary, renal or liver diseases and
none was receiving cardiac medications before operation.
Patients with Glasgow Coma Scale score less than 13 and
patients with signs of increased intracranial pressure
(ICP), were excluded. Tumor characteristics likely to affect
the brain relaxation intraoperatively, especially the tumor
size, histology, perifocal edema, and midline shift all were
well matched for both groups by the preoperative radiolog-
ical scans. All patients were thoroughly assessed preopera-
tively by history, physical examination and laboratory
evaluations (complete blood picture, liver function and re-
nal function tests). Patent foramen ovale (PFO) was ex-
cluded either by transoesophageal echocardiography (TOE)
or transthoracic echocardiography and once diagnosed,
the patient was excluded for fear of the risk of paradoxical
air embolism (PAE). On arrival to the operating theater
wide bore intravenous cannula (18 G) was inserted through
suitable peripheral vein. I.V. midazolam 0.05 mg/kg and
fentanyl 1.5 lg/kg were given and incremental dose of fen-
tanyl was repeated intra operatively according to the hemo-
dynamic state and the anesthesiologist’ prescription. After
randomization using sealed envelopes, patients were as-
signed to receive either mannitol (20%) 1 gm/kg just before
opening the dura (GI) for intraoperative brain relaxation or
normal saline; placebo group (GII), infused through the
central line starting with scalp incision at a rate of
20 mL/min in both groups. Both ﬂuids were administered
over 15–20 min using an infusion pump with the type of
ﬂuid blinded to both surgeon and anesthesiologist.
Preanesthetic monitoring included pulse, ECG, non-inva-
sive blood pressure, and peripheral O2 saturation. After pre-
oxygenation with 100% O2 for 5 min, anesthesia was induced
using I.V. thiopental sodium 5–7 mg kg1, with loss of con-
sciousness, the trachea was intubated with a suitable armored
cuffed endotracheal tube 2 min after an induction dose of
atracurium besylate (0.5 mg/kg) to facilitate intubation, fol-
lowed by top up doses of 1/5 of the initial dose of atracurium
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were mechanically ventilated using Drager (Fabius GS-Ger-
many) ventilator with tidal volume of 8–10 ml/kg and I/E ratio
1:2 through closed circuit with fresh gas ﬂow around 3 l.
End-tidal CO2 was monitored using Drager (Inﬁnity Kappa,
Mexico) monitor with Samsung screen with main stream cap-
nograph and minute ventilation was modiﬁed to maintained
EtCO2 between 30 and 35 mm Hg to avoid an inﬂuence of car-
bon dioxide on the brain bulk, until it was assessed by the sur-
geon. Then, if needed, hyperventilation was initiated by the
attending anesthesiologist’s choice.
‘‘Anesthetic maintenance included 1% sevoﬂurane in oxy-
gen: air mixture (1:1) combined with IV infusion of propofol
(dose range, 1–2 mg/kg/h) and an IV bolus of fentanyl and
atracurium, if necessary, which were administered at the
attending anesthesiologist’s discretion.’’
Perioperative ﬂuid requirement was maintained with
crystalloid solution (normal saline 0.9% or ringer solution),
and it was guided by CVP values and urine volume. No
blood was given unless there was severe blood loss (more
than 20% of total blood volume) and/or hematocrit value
630%.
A radial artery was cannulated after the induction of anes-
thesia in non-dominant hand (after performance of modiﬁed
Allen’s test) under aseptic conditions to obtain blood samples.
Central venous single lumen catheter (18 G) (Amecath,
France) was inserted in the right subclavian vein with strict
sterile technique using Sildenger technique. The catheter was
then ﬂushed with heparinized normal saline solution and con-
nected to a pressure transducer for central venous pressure
monitoring with transducer referenced to the level of ear tra-
gus during the sitting position. The position of the catheter
was conﬁrmed by antero posterior chest X-ray just after inser-
tion by C-arm.
Before being placed in the sitting position, patients were
dressed in an antigravity elastic bandages wrapped around
the calves and thighs to decrease venous pooling in the lower
extremities. The patient’s head was pinned and ﬁxed with the
Mayﬁeld head holder (Mayﬁeld; Integra Life Sciences, USA)
before placement in the sitting position. In the sitting position,
the patient’s upper body was elevated 90–100, and the pa-
tient’s head was tilted 20–30 forward to allow the patient to
sit ﬁrmly with knees slightly ﬂexed on the pillow. The exposure
of the infratentorial region requires ﬂexion of the head, but to
avoid damage to the spinal cord, a 2-ﬁnger breadth distance
between the chin and sternum is mandatory. On suspicion of
venous air embolism (VAE), a sudden decrease in the EtCO2
of 0.7 kPa (5.25 mm Hg) almost equal to 0.7% [6] without
prior change in the ventilation or concomitant decrease in
the arterial pressure, the neurosurgeon is immediately notiﬁed.
Jugular veins were gently compressed manually to help the
neurosurgeon to identify the source of air entry. The neurosur-
geon closes the leak by applying wax or gel foam in the bone
bleeds or surgical closure of the dural sinus bleeds either by
suturing or by haemostatic materials. Cautery was used to con-
trol muscle bleeder. When the site of the air entry is not found
by pressure of the jugular veins, the operative site was covered
with compresses soaked in saline for a while; the compresses
were slowly removed observing all possible sites of air entry.
Aspiration of air from the circulation can be attempted via
the central venous catheter. If hemodynamic collapse occurs,
the operating table is tilted.Heart rate (HR), mean arterial blood pressure (MBP), arte-
rial oxygen saturation (SPO2),end tidal carbon dioxide (EtCO2)
and central venous pressure (CVP) were recorded before induc-
tion (basal) and post-induction, after sitting, 30 min from start
of surgery and every 30 min till the end of surgery.
Serum sodium and potassium concentration and serum
osmolarity was measured at a basal reading (preoperatively),
post-induction, after half dose of mannitol infusion, after full
dose of mannitol infusion, 1 h post-infusion, 90 min, 120 min
and at recovery room.
Brain relaxation was determined by the surgeon during
opening the dura on a four-point scale: 1 = perfectly relaxed,
2 = satisfactorily relaxed, 3 = ﬁrm (leveled) brain, 4 = bulg-
ing brain immediately after opening the dura [7].
At the end of the surgery, patients were transferred to sur-
gical intensive care for at least 24 h with full monitoring, and
any complications were recorded (either intra-operative or
postoperative).
For calculation of power analysis, we assumed a difference
of 1 point in brain relaxation score between the groups to be
clinically signiﬁcant. A power of analysis based on 95% con-
ﬁdence interval and type-I error protection of 0.05 and an ef-
fect size convention of 0.8, a total sample size of 70 patients
(35 patients in each group) produced a power of 0.95. But we
recruited 80 cases to overcome the possibility of drop out
cases.
The statistical analysis of data was done by using excel pro-
gram for ﬁgures and SPSS (SPSS, Inc, Chicago, IL) program
statistical package for social science version 16. The t test
was used for data proved to be normally distributed (the
Kolmogrove Smirnov test). Only signiﬁcant data revealed to
be nonparametric. NB: all tested data revealed to be paramet-
ric. The description of the data done in form of mean (±/)
SD for quantitative data and frequency and proportion for
qualitative data. The analysis of the data was done to test sta-
tistical signiﬁcant difference between groups. Chi square test
was used for qualitative data. Any difference or change show-
ing probability (p) less than 0.05 was considered statistically
signiﬁcant at conﬁdence interval 95%.3. Results
The ﬂow diagram of participation in this study is shown in
Fig. 1. One patient of mannitol group had a massive air embo-
lism (requiring correction of the patient’s position and resusci-
tation) and two of placebo group (one exposed to unblinding
and the other patient had sever hemorrhage with hemody-
namic instability) were excluded from the analysis of the study
outcomes (Fig. 1). In this study, there were no signiﬁcant dif-
ferences between mannitol group and placebo group with re-
spect to age (20–60 years), weight (55–90 and 55–82 kg,
respectively). All patients were ASA I and II (ASA I/ASA
II = 21/18 and 23/15, respectively). The duration of surgery
and the duration of hospital stay also showed no signiﬁcant
intergroup differences (Table 1).
Estimated blood loss displayed no signiﬁcant difference be-
tween the studied groups (647.250 ± 173.972 ml) in mannitol
group versus (650.000 ± 171.389 ml) in placebo group (p va-
lue = 0.943) (Table 1) .
The total amount of the urine output, at the end of the pro-
cedure reﬂected a highly signiﬁcant difference between the
Figure 1 Consort ﬂow diagram.
Table 1 Patients characteristics, duration of surgery (min) and total urine output (ml) of the studied groups. Values are presented as
mean ± SD, (number) and (%) for ASA classiﬁcation.
GI (N= 39) GII (N= 38) p Value
N % N %
ASA
I 21 53.8% 23 60.5% 0.62
II 18 46.2% 15 39.5%
Age (years) 41.90 ± 9.46 42.37 ± 10.19 0.83
Sex
M 20 51.3% 17 44.7% 0.35
F 19 48.7% 21 55.3%
Wt (kg) 71.25 ± 8.19 68.55 ± 6.94 0.11
Duration of surgery (min) 177.37 ± 15.40 177.50 ± 15.48 0.97
Duration of hospital stay (day) 6.47 ± 1.89 7.05 ± 1.96 0.18
Estimated blood loss (ml) 647.250 ± 173.972 650.000 ± 171.389 0.943
Total urine output (ml) 1683.7750 ± 381.237* 815.5000 ± 209.724 0.001
GI =Mannitol group.
GII = Placebo group.
* Signiﬁcant difference between GI and GII (p< 0.05).
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versus (815.5000 ± 209.724) in placebo group (p va-
lue < 0.001) (Table 1).The pathological lesions were located mainly in the poster-
ior fossa and showed no any signiﬁcant difference between
both groups (Table 2).
Table 2 Type of the lesions. Values are presented as numbers
of the patients.
Type of lesions GI (n= 39) GII (n= 38) p Value
Cerebellopontine angle
tumor(CPA)
13 14 0.956
Cerebellar tumor 10 8
Occipital lobe 8 8
Brain stem lesion 5 4
Pineal body tumor 3 4
GI =Mannitol group.
GII = Placebo group.
Table 3 Complications of the studied groups. Values are
presented as numbers of the patients.
Type of complications GI (n= 39) GII (n= 38) p Value
No. % No. %
Air embolism 2 5 2 5 0.69
Pneumocephalus 4 10 1 2.5 0.17
Neurological deﬁcits 1 2.5 1 2.5 0.75
GI =Mannitol group.
GII = Placebo group.
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there were two cases who developed a shower of air embolism
in both groups. Although pneumocephalus occurred in four
cases in mannitol group and in one case in placebo group, it
did not represent signiﬁcant difference between both groups
(p= 0.17). Neurological deﬁcit in the form of transient ulnar
nerve concussion developed in one case in both groups
(Table 3).
Heart rate and mean arterial blood pressure demonstrated
no signiﬁcant difference between both groups throughout the
study period (Fig. 2). Heart rate was increased post-induction
in both groups compared with the baseline values. Mean blood
pressure was decreased signiﬁcantly after sitting, 30 min, 1 h,
90 min from start of surgery in both studied groups in compar-
ison to the baseline values.
Peripheral arterial oxygen saturation (SPO2) was signiﬁ-
cantly increased in both groups at 1 h, 90 min and 120 min
from the start of surgery (p< 0.01) and signiﬁcantly increased
only in placebo group at 30 min compared with basal values
(p 6 0.001) (Table 4). At the same time, the end tidal carbon
dioxide (EtCO2) displayed signiﬁcant increase in the mannitol
group in comparison to the placebo group (p 6 0.01 to
p 6 0.02), where as it showed a highly signiﬁcant decrease in
mannitol group at 30 min from the start of surgery compared
with both basal value and the placebo group (p 6 0.001) (Ta-
ble 4).
Regarding central venous pressure in mannitol group, it re-
vealed a signiﬁcant increase (p< 0.01) at 30 min from start of
surgery then it returned gradually to nearby the initial basal
values (Fig. 3).
Fourteen patients in mannitol group had a brain relaxation
score (BRS) 1 versus ten patients in placebo group without sig-
niﬁcant difference between both groups. Twelve patients inmannitol group versus eleven patients in placebo group had
BRS 2. Seven patients in mannitol group versus nine patients
in placebo group had BRS 3. Six patients in mannitol group
versus eight patients in placebo group had BRS 4. Brain relax-
ation score displayed no signiﬁcant difference between the
studied groups (p= 0.719) (Fig. 4).
Serum sodium level concentration showed a highly signiﬁ-
cant decrease in mannitol group (p< 0.001) compared with
placebo group after half dose of mannitol infusion till 90 min
post-infusion (Fig. 5). Whereas mannitol group displayed a
signiﬁcant increase of serum potassium level concentration
compared with placebo group starting after half dose of man-
nitol infusion, after full dose of mannitol infusion and at 1 h
post-infusion (p< 0.001) (Fig. 6). Serum osmolarity showed
signiﬁcant increase in mannitol group (p< 0.001) compared
with placebo group after half dose of mannitol infusion till
120 min post-infusion (Fig. 7).4. Discussion
In the present study, both groups; mannitol and placebo were
compared as regard hemodynamic, brain relaxation score, ser-
um sodium, potassium and osmolarity and any operative com-
plications. Patients in both groups demonstrated comparable
both demographic characteristics included the types of lesions
and hemodynamic included HR and MBP. Mannitol group
displayed signiﬁcant increase in end tidal carbon dioxide and
serum potassium and osmolarity compared with placebo
group, whereas it demonstrated a signiﬁcant decrease in EtCO2
at 30 min from the start of surgery compared with the basal va-
lue. Peripheral arterial oxygen saturation was signiﬁcantly
higher in both groups at most of the study periods compared
with basal values. Mannitol group displayed signiﬁcant hypo-
natremia compared with placebo group. Mannitol group dem-
onstrated signiﬁcant increase in urine output than placebo
group.
Since 1913, when the ﬁrst surgery with the patient in sitting
position was performed, the debate concerning this positioning
has continued [8]. The sitting position is thought to be the best
for surgical access to the posterior fossa or to dorsally located
parietal lesions. In addition to increased risk of venous air
embolism, the hemodynamic disturbances following the sitting
position were evident [9]. Based on this concept, in the current
study, we tried to minimize this hemodynamic and electrolytes
derangement associated with the sitting position through
avoiding the use of mannitol which might causes a further dis-
turbances in hemodynamics in addition to its unwanted effect
on the serum electrolytes with its subsequent effect on such
group of patients.
There is a well-documented transient intracranial pressure
(ICP) reducing effect of mannitol, but an adverse rebound in-
crease in ICP after its withdrawal has been discussed exten-
sively in the literature and is an expected pathophysiological
phenomenon [10].
In our study, although the number of patients in mannitol
group with a perfectly and satisfactory brain relaxation were
more than those in the placebo group, it did not represent sta-
tistical signiﬁcance between both groups. Also, the number of
patients in placebo group with ﬁrm and rigid brain was more
than those in the mannitol group, but this was not represents
signiﬁcant difference between both groups. Previously, the
Table 4 End tidal carbon dioxide EtCO2 (mmHg) and arterial oxygen saturation (SPO2%) of the studied groups. Values are
mean ± SD.
EtCO2 p Value SPO2 p Value
GI (n= 39) GII (n= 38) GI (n= 39) GII (n= 38)
Basal after intubation 37.25 ± 2.89 37.32 ± 2.93 0.90 98.42 ± 0.98 98.40 ± 0.98 0.91
After sitting 33.17 ± 2.61 32.70 ± 2.98 0.45 99.70 ± 0.46 99.55 ± 0.55 0.19
30 min from start of surgery 28.45 ± 3.58** 33.40 ± 3.63* 0.001 97.60 ± 14.21 99.77 ± 0.42** 0.001
1 h 34.92 ± 1.81 33.35 ± 2.04* 0.01 99.85 ± 0.36** 99.25 ± 0.43** 0.01
90 min 36.87 ± 0.79 36.00 ± 1.17* 0.01 99.72 ± 0.55** 99.00 ± 0.32** 0.01
120 min 37.32 ± 0.70 36.78 ± 1.13* 0.02 99.17 ± 0.38** 99.45 ± 0.50** 0.01
180 min 32.55 ± 2.13 33.15 ± 2.62 0.26 99.35 ± 0.62 99.30 ± o.46 0.68
150 min 35.12 ± 1.43 35.20 ± 1.84 0.84 99.02 ± 0.27 99.05 ± 0.31 0.70
210 min 37.50 ± 31.80 37.33 ± 0.98 0.27 99.57 ± 0.50 99.45 ± 0.50 0.26
GI =Mannitol group.
GII = Placebo group.
* Signiﬁcant difference between GI and GII (p< 0.05).
** Signiﬁcant difference with basal values (p< 0.05).
(A)
(B)
Figure 2 (A) HR of the studied groups (beat/min); (B) MBP of the studied groups (mm Hg). \Statistically signiﬁcant compared to the
baseline value.
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Figure 3 Central venous pressure (CVP, mm Hg) of the studied groups. Values are in numbers. \ = Signiﬁcant difference between GI
and GII (p< 0.05). GI =Mannitol group. GII = Placebo group.
Figure 4 Brain relaxation score (BRS) of the studied groups. Values are in numbers. Four-point scale score of brain relaxation:
1 = perfectly relaxed, 2 = satisfactorily relaxed, 3 = ﬁrm (leveled) brain, 4 = bulging brain. GI =Mannitol group. GII = Placebo
group.
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intracranial pressure has been investigated in two studies in
patients undergoing elective craniotomies for various
neurosurgical procedures [11,12]. Gemma et al. reported satis-
factory brain relaxation in all cases, when a different osmolar
load but similar volume of 7.5% HS (n= 25) and 20% man-
nitol (n= 25) was given to patients. De Vivo et al. compared
three different regimens and combinations of mannitol and
HS: (1) 0.5-g/kg bolus of mannitol (n= 10) versus (2) 0.25-
g/kg bolus of mannitol followed by continuous infusion of
3% HS (n= 10) versus (3) bolus of 3% HS followed bycontinuous infusion of 2% and 1% HS (n= 10). Using the
scale of brain relaxation similar to ours, the authors did not
ﬁnd any difference between the groups.
The patients in our study displayed no signiﬁcant hemody-
namic difference between the studied groups. It is possible that
blood pressure ﬂuctuations were controlled by anesthesia man-
agement, masking an acute response to study solutions, but
this is considered unlikely because no speciﬁc hemodynamic
pattern emerged during the study. Another studies proved that
the sitting position is often associated with haemodynamic
instability, in particular a decrease in mean arterial pressure,
Figure 5 Serum sodium concentration (Na+) (meq/L) of the studied groups. Values are in numbers.\ = Signiﬁcant difference between
GI and GII (p< 0.05). GI =Mannitol group. GII = Placebo group.
Figure 6 Serum potassium concentration (K+) (meq/L) of the studied groups. Values are in numbers. \ = Signiﬁcant difference between
GI and GII (p< 0.05). GI =Mannitol group. GII = Placebo group.
262 S.A. Mousa et al.stroke volume index and cardiac index [13,14]. It could be as-
sumed that the cardiovascular effects of the sitting position are
caused mainly by a reduction in cardiac preload [15].
The reduction of the mean arterial blood pressure observed
in our study in comparison to the baseline values was in accor-
dance to the previous study, in which the arterial hypotension,
deﬁned as a decrease in mean arterial pressure of >10% or a
decrease in systolic arterial pressure of >20% with an inci-
dence of 5–32% [16].
CVP was increased by mannitol group at 30 min after the
start of surgery, consistent with an initial intravascular volume
expansion, determined by the increase in serum osmolality.
The same result was observed by Rozet et al., in their study
on the effect of equiosmolar solutions of mannitol versus
hypertonic saline on intraoperative brain relaxation and elec-
trolyte balance [17].
In the current study the signiﬁcant increase in the level of
end tidal carbon dioxide in mannitol group (EtCO2) might
be explained by the initial increase in the blood volume thataccompanied the mannitol infusion with consequent increase
in the pulmonary blood ﬂow. Apart from the quantity and rate
of mannitol infused, the duration of the blood volume increase
is dependent on both the rate of equilibration of mannitol in
the extracellular compartments and the rate of renal excretion
of mannitol with the resulting osmotic diuresis [18]. In this
study the EtCO2 reached its maximum at the termination of
the mannitol infusion and returned gradually to near the con-
trol levels later on. At the same time the peripheral arterial
oxygen saturation was signiﬁcantly increased concomitant
with the gradual raising of the body to the sitting position
which might be attributed to the relieving effect on the thoracic
cage away from the abdominal content improving the process
of ventilation.
The majority of the cardiovascular effect observed during
this study did not occur when patients were placed in the
seated position, but rather occurred with infusion of mannitol
which might support our hypothesis of lacking interest for the
use of mannitol in such group of patients.
Figure 7 Serum osmolarity (mmol/L) of the studied groups. Values are in numbers. \ = Signiﬁcant difference between GI and GII
(p< 0.05). GI =Mannitol group. GII = Placebo group.
Brain relaxation and electrolyte balance during resection of posterior fossa tumors 263Estimated blood loss displayed no signiﬁcant difference be-
tween the studied groups that could be assumed to the sitting
position attained in both groups in which, accumulated blood
drains out of and away from the operative site, permitting
more rapid access to bleeding points, a cleaner surgical ﬁeld
and a technically easier procedure irrespective to the use of
mannitol or not.
In this study, surgery was performed by 1 of senior neuro-
surgeon. Although serious complications were not observed,
the prognosis of brain tumor surgery was inﬂuenced by many
factors, including the size and the location of the tumor, the
severity of the adjacent tissue damage, the residual function
after tumor excision, and the immune or inﬂammatory re-
sponses to the procedure. The results of hospital stay days in
the 2 groups were similar, perhaps because (1) these 2 studied
groups were affected mainly by the factors described above,
rather than by the effects of mannitol on brain relaxation;
(2) signiﬁcant differences may have been present mainly at
the cellular level or at the cognitive function level, which was
beyond the scope of our study; (3) even though mannitol
yielded a greater effect on brain relaxation, it is very important
to note that a reduction in brain volume does not necessarily
translate into a better cerebral outcome [19].
Venous air embolism (VAE) is the entrainment of air into
the venous system from the operative site or another commu-
nication with the environment. Venous air embolism is a fre-
quent event in patients undergoing posterior fossa surgery
while in the sitting position, occurring in 45% of patients in
the study done by Black and Cucchiara, on the outcome fol-
lowing posterior fossa craniectomy in patients in the sitting
or horizontal position [20].
In the current study, the incidence of venous air embolism
was not more than 5% in both groups. Really, we depend up
on the end tidal carbone dioxide as the only tool for detection
of venous air embolism, which might affect the sensitivity of
detection. The most commonly used methods are transoesoph-
ageal echo (TOE), precordial Doppler, EtCO2, right heart
catheterization, and oesophageal stethoscope in decreasing or-
der of sensitivity for air detection [20]. In the current study, thehighly signiﬁcant decrease in the EtCO2 (p< 0.001) at 30 min
from the start of surgery that observed in mannitol group com-
pared with the basal value might be attributed to the occur-
rence of shower of venous air embolism (VAE) reﬂected on
the sudden decrease in EtCO2 during the opening of the cra-
nium or the dura. In this study, the unaltered hemodynamics
in patients during VAE indicates relatively small VAE. Possi-
ble explanations for this are early recognition of air leakage
and good cooperation between the surgical and anesthesia
teams.
Pneumocephalus occurs due to air entry into the dural or
the epidural spaces under pressure and in sufﬁcient volumes
to exert dangerous mass effect potential for life threatening
brain herniation [21]. In the current study, although the inci-
dence of pneumocephalus showed no signiﬁcant difference be-
tween the studied groups, the number of patients belonged to
mannitol group (10%) were more than those in the placebo
group (2.5%), which might be attributed to diminution of
the brain volume secondary to mannitol administration. This
complication has been described in association with posterior
fossa tumor resection in the sitting position by many authors
[22,23]. In one large study, the incidence of pneumocephalus
following posterior fossa surgery in sitting position was 3%
[24].
The changes in serum sodium, potassium and osmolality in
mannitol group of our study are similar to previous investiga-
tions of low dose mannitol [25,26]. In the current study, man-
nitol caused an immediate decrease in sodium in blood and an
increase in potassium and osmolarity over time till 1 h post-
infusion where both electrolytes start to return near to the
baseline values later on (Figs. 5–7).
Physiologic effects of hyperosmotic ﬂuids on the brain have
been compared in multiple animal and human studies with var-
ious brain pathologies [27,28]. The principal mechanism of ac-
tion of mannitol is the creation of an osmolar gradient across
the BBB due to impermeability of the BBB to mannitol. There-
fore, an intact BBB is required for intravascular water absorp-
tion. Indeed, a decrease in intracranial pressure with increased
serum osmolality, and decreased brain water content with
264 S.A. Mousa et al.hyperosmotic treatment in healthy, but not injured, brain tis-
sue has been shown in animals [29]. In humans, a correlation
between an increased concentration in serum sodium and
osmolality and a decrease in intracranial pressure and brain
water content in noninjured brain areas has been shown in pa-
tients with traumatic brain injury and brain tumors, treated
with either hypertonic saline (HS) or mannitol [30]. In this re-
gard, our data showing equally effective brain bulk reduction
with mannitol was consistent with the classic theory of hyper-
osmotic therapy. Mannitol caused an acute hyponatremia but
a stepwise increase of potassium over time. Different changes
of potassium such as hypokalemia and hyperkalemia have
been previously reported with mannitol [31]. Hyperkalemia
after mannitol administration has been reported [32], but the
exact mechanism of this phenomenon is unknown. One of
the suggestions includes a cellular potassium efﬂux with the
water, as a result of hyperosmolar condition [33]. Administra-
tion of mannitol increases serum sodium concentration or
osmolality and decreases ICP and brain water content in non
injured brain areas, as shown in human and animal studies
[34,35]. The principal mechanism underlying these effects is
the induction of a water shift from brain tissues to the intra-
vascular space by the hyperosmolarity of mannitol because
the blood brain barrier (BBB) is impermeable to mannitol.
At the end of the study, the total urine output was signiﬁcantly
increased with mannitol group indicating an ongoing osmotic
diuresis with the risk of accentuating the already disturbed
electrolytes state.
5. Conclusion
Tumor of the posterior fossa can easily operated without the
use of mannitol with accepted hemodynamic condition, rea-
sonable metabolic state and no signiﬁcant difference in brain
relaxation score (BRS), the amount of intraoperative blood
loss and the operative complications between both groups.6. Financial support
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